| Literature DB >> 26175901 |
Maike Bublitz1, Karol Nass2, Nikolaj D Drachmann1, Anders J Markvardsen3, Matthias J Gutmann3, Thomas R M Barends2, Daniel Mattle1, Robert L Shoeman2, R Bruce Doak4, Sébastien Boutet5, Marc Messerschmidt5, Marvin M Seibert5, Garth J Williams5, Lutz Foucar2, Linda Reinhard1, Oleg Sitsel1, Jonas L Gregersen1, Johannes D Clausen6, Thomas Boesen1, Kamil Gotfryd7, Kai-Tuo Wang1, Claus Olesen6, Jesper V Møller6, Poul Nissen8, Ilme Schlichting2.
Abstract
Membrane proteins are key players in biological systems, mediating signalling events and the specific transport of e.g. ions and metabolites. Consequently, membrane proteins are targeted by a large number of currently approved drugs. Understanding their functions and molecular mechanisms is greatly dependent on structural information, not least on complexes with functionally or medically important ligands. Structure determination, however, is hampered by the difficulty of obtaining well diffracting, macroscopic crystals. Here, the feasibility of X-ray free-electron-laser-based serial femtosecond crystallography (SFX) for the structure determination of membrane protein-ligand complexes using microcrystals of various native-source and recombinant P-type ATPase complexes is demonstrated. The data reveal the binding sites of a variety of ligands, including lipids and inhibitors such as the hallmark P-type ATPase inhibitor orthovanadate. By analyzing the resolution dependence of ligand densities and overall model qualities, SFX data quality metrics as well as suitable refinement procedures are discussed. Even at relatively low resolution and multiplicity, the identification of ligands can be demonstrated. This makes SFX a useful tool for ligand screening and thus for unravelling the molecular mechanisms of biologically active proteins.Entities:
Keywords: P-type ATPases; XFEL; ligand screening; serial femtosecond crystallography
Year: 2015 PMID: 26175901 PMCID: PMC4491313 DOI: 10.1107/S2052252515008969
Source DB: PubMed Journal: IUCrJ ISSN: 2052-2525 Impact factor: 4.769
Figure 1Diffraction pattern, electron density and structure of SERCA–Ca2–AMPPCP. (a) Representative diffraction pattern of SERCA–Ca2–AMPPCP microcrystals. The boxed inset shows a strong Bragg spot at 2.8 Å resolution {Miller index [31, −15, 24], 〈I/σ(I)〉 = 8.4}. (b) Left, overall 2mF o − DF c electron-density map (contoured at 1.0σ) after final refinement including coordinates and B factors for all atoms and data to 2.8 Å resolution; right, molecular model, including ten transmembrane helices and cytoplasmic N (nucleotide binding), P (phosphorylation) and A (actuator) domains. The 13 structural segments initially refined as rigid groups are shown in different colours. Ligand-binding regions are indicated by numbers: 1, AMPPCP; 2, Ca2+ ions; 3, lipid.
Data-collection and refinement statistics
Values in parentheses are for the outer shell except where indicated otherwise.
| SERCACa2AMPPCP | SERCAVO3TNPATP | SsZntAAlF4 | |
|---|---|---|---|
| Data-collection and processing | |||
| X-ray energy (keV) | 6 | 6 | 6 |
| Collected frames | 761730 | 1371609 | 280281 |
| Diffraction hits | 23016 (3.0) | 83934 (6.1) | 16358 (5.8) |
| Indexed frames | 4069 (17.8) | 4910 (5.8) | 55 (0.3) |
| Space group |
|
|
|
|
| 162, 76.3, 151 | 268, 268, 114.5 | 58, 58, 320 |
| , , () | 90, 109.0, 90 | 90, 90, 90 | 90, 90, 90 |
| Highest resolution observed () | 2.8 | 4 | 4 |
| Resolution range for processing () | 59.92.8 (2.92.8) | 57.255.00 (5.185.00) | n.a. |
| Unique reflections | 42416 (3652) | 18601 | n.a. |
| Multiplicity | 17.3 (4.2) | 124 (117) | n.a. |
|
| 1.13 (0.39) | 2.03 (0.34) | n.a. |
|
| 62.3 (538) | 22.5 (424) | n.a. |
| CC1/2 | 0.70 (0.03) | 0.97 (0.16) | n.a. |
| CC* | 0.90 (0.25) | 0.99 (0.53) | |
| Anomalous CC | n.a. | 0.06 (0.03) | n.a. |
| Completeness (%) | 98.1 (85.5) | 99.91 (100) | n.a. |
| Molecular replacement | |||
| Search-model PDB code |
|
| |
| Rotation-function | 8.4 | 2.3/1.8 | |
| Translation-function | 10.6 | 11.5/20.4 | |
| Log-likelihood gain | 4295 | 991 | |
| Refinement | |||
| Resolution () | 602.80 (2.912.80) | ||
| No. of reflections | 41471 (3500) | ||
| Final | 30.4/34.3 (47.5/49.9) | ||
| No. of non-H atoms | |||
| Protein | 7671 | ||
| Ca2+ | 3 | ||
| K+ | 1 | ||
| AMPPCP | 31 | ||
| Total | 7706 | ||
| R.m.s. deviations | |||
| Bonds () | 0.006 | ||
| Angles () | 0.762 | ||
| Average | |||
| N domain | 97.7 | ||
| P domain | 97.6 | ||
| A domain | 114 | ||
| TM domain | 130.3 | ||
| Ca2+ | 113 | ||
| K+ | 91.0 | ||
| AMPPCP | 88.6 | ||
| Ramachandran plot | |||
| Most favoured (%) | 95.1 | ||
| Allowed (%) | 4.4 | ||
Numbers in parentheses are the percentage of the total collected frames.
Numbers in parentheses are the percentage of indexed frames.
The Zn2+-ATPase data set was not merged because the number of indexed patterns was too low to obtain meaningful merged data.
The according numbers of unique reflections when merged with Friedel pairs treated as separate reflections is 31576 (3262).
R split is defined in CrystFEL as the R factor between data sets calculated from two randomly chosen halves of the data, corrected for the decrease in multiplicity caused by dividing the data into halves: R split = .
Determined from processing the data set with separated Friedel mates.
See 2 for details of how the search models were prepared to remove model bias.
Figure 2R work and R free values resulting from different refinement strategies. (a) R values after refinement with increasing numbers of parameters, including data to 4.0 Å resolution. (b) Differences in R values after refinement (all atom coordinates, individual B factors) depending on the chosen high-resolution data cutoff. Models were refined in parallel to both the lower and the higher resolution cutoff and the R values were compared at the lower cutoff. The range of lower data quality between 3.6 and 3.4 Å is probably caused by high background scattering owing to the solvent.
Figure 3Plot of free R factor against resolution after refinement (all atom coordinates, individual B factors) to 2.8 Å resolution against the original data set (dashed black lines) and hybrid data sets (red lines) with scrambled intensities. The arrows indicate the beginning of the scrambled data at (a) 5.82 Å, (b) 4.62 Å, (c) 4.04 Å, (d) 3.67 Å, (e) 3.41 Å, (f) 3.21 Å, (g) 3.04 Å and (h) 2.91 Å. These cutoffs were chosen in accordance with the resolution shells used by phenix.refine to calculate the R free values of the model.
Figure 4Electron density for SERCA ligands at different resolutions. Upper panels depict the nucleotide-binding site (region 1 in Fig. 1 ▸ b) and lower panels the Ca2+-binding site (region 2 in Fig. 1 ▸ b). Green mesh, mF o − DF c map after refinement without any ligands contoured at 3.0σ. Refinements with resolution cutoffs lower than 3.4 Å were restricted to 13 rigid-body groups, whereas refinements including data to 3.4 Å resolution or higher included individual atom coordinates and B factors. The expected ligand positions are superposed on all panels for Ca2+ and on the last panel for Ca2+–AMPPCP (PDB entry 3n8g). For a quantification of the density coverage around the ligands, see Supplementary Figs. S3 and S4.
Figure 5Electron density of SERCA ligands. A peak of ∼6σ in the mF o − DF c OMIT map after refinement without ligands (all atom coordinates, individual B factors) against data to 2.8 Å resolution overlaps with (a) a phosphatidylcholine modelled in the E1–ADP–AlF4 form (stick representation; PDB entry 2zbd; Toyoshima et al., 2004 ▸) and (b) the N-terminal part of regulatory sarcolipin (grey cartoon; PDB entry 4h1w; Winther et al., 2013 ▸). (c) mF o − DF c OMIT map (green, 3.0σ; red, −3.0σ) calculated to 5 Å resolution at the vanadate- and TNPATP-binding sites. The side chain of the catalytic residue Asp351 is shown in stick representation.
Figure 6Statistics for SFX data from SERCA–Ca2–AMPPCP. (a) R split and (b) correlation coefficient between random half data sets, CC1/2, against resolution.